Diet in Cancer Treatment

By Dr Ann-Mary Amber, Integrative Doctor

Diet plays a central role in cancer care, not only in prevention but also in supporting patients throughout treatment and survivorship. Cancer therapies such as chemotherapy, radiotherapy, surgery, targeted agents, and immunotherapy impose significant physical stress, often impairing nutritional status and quality of life. A well-structured diet can help mitigate treatment side effects, strengthen immunity, improve tolerance to therapy, and enhance recovery (Arends et al., 2017).

Nutritional Goals in Cancer Care

The key goals of dietary support during cancer treatment include:

• Maintaining lean body mass and preventing cachexia (Muscaritoli et al., 2021).
• Reducing inflammation and oxidative stress, which contribute to treatment side effects and cancer progression (Rock et al., 2022).
• Supporting immune function, crucial in patients undergoing chemotherapy or immunotherapy (Zhang & Zhang, 2019).
• Stabilizing blood sugar and insulin sensitivity, since hyperglycemia and obesity are associated with poorer outcomes (Ligibel et al., 2020).
• Improving gastrointestinal health by protecting and restoring the gut microbiome, which influences metabolism, immunity, and treatment response (Alexander et al., 2017).

Core Components of an Anti-Cancer Diet

1. Plant-Forward Approach
   A diet rich in vegetables, fruits, whole grains, legumes, nuts, and seeds provides phytonutrients, flavonoids, and fiber. These compounds exert antioxidant, anti-inflammatory, and anti-proliferative effects (Hanahan, 2022). Cruciferous vegetables (broccoli, cauliflower, kale) supply sulforaphane, which promotes detoxification and supports healthy estrogen metabolism (Clarke et al., 2008).
2. Protein for Repair and Recovery
   Cancer patients often experience increased protein needs due to tissue repair, muscle preservation, and immune system demands. Lean poultry, fish, legumes, soy, and dairy can help. In some cases, plant-based powders can support patients with poor appetite or swallowing difficulties (Arends et al., 2017).
3. Healthy Fats
   Omega-3 fatty acids (from oily fish, flaxseeds, walnuts) have anti-inflammatory effects, support cognitive function, and may reduce treatment-related side effects such as cachexia or neuropathy (Laviano et al., 2020).
4. Glycemic Control
   Diets high in refined sugars and processed carbohydrates can increase insulin and IGF-1 signaling, pathways linked to cancer progression (Giovannucci et al., 2010). A low-glycemic diet emphasizing whole foods, high fiber, and balanced macronutrients helps maintain stable glucose levels.
5. Hydration
   Adequate fluid intake is essential, particularly during chemotherapy and radiotherapy, to support detoxification, kidney function, and bowel regularity (Rock et al., 2022).

Special Considerations

• Managing Treatment Side Effects:
  • Nausea/vomiting: ginger, bland starchy foods (Zick et al., 2009).
  • Mucositis: smooth, soft foods (Lalla et al., 2014).
  • Diarrhea: low-fiber diet, probiotics if tolerated (Redman et al., 2021).
  • Constipation: high fiber, prunes, hydration (Arends et al., 2017).
• The Microbiome:
  Emerging evidence highlights the gut microbiome’s role in modulating immune response, especially during immunotherapy (Gopalakrishnan et al., 2018).
• Weight Management:
  Both unintended weight loss and obesity worsen prognosis. Individualized dietary strategies are critical (Ligibel et al., 2020).

Supplements and Caution

While specific supplements (vitamin D, selenium, zinc, medicinal mushrooms) may support immunity, they must be used under supervision. (Block et al., 2008).

Conclusion

An anti-cancer diet is not a single prescription but a personalized, whole-food approach. By emphasizing nutrient-dense, plant-forward meals, adequate protein, healthy fats, glycemic control, and microbiome support, diet becomes a powerful adjunct in cancer treatment. Proper nutrition improves quality of life, enhances therapeutic efficacy, and empowers patients in their recovery and survivorship.

References

• Alexander, J.L., et al. (2017). Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology & Hepatology, 14(6), 356–365.
• Arends, J., et al. (2017). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 36(1), 11–48.
• Block, K.I., et al. (2008). Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review. Cancer Treatment Reviews, 34(5), 407–418.
• Clarke, J.D., et al. (2008). Sulforaphane, a naturally occurring isothiocyanate, induces phase II detoxification enzymes. Cancer Letters, 269(2), 291–304.
• Giovannucci, E., et al. (2010). Diabetes and cancer: A consensus report. CA: A Cancer Journal for Clinicians, 60(4), 207–221.
• Gopalakrishnan, V., et al. (2018). Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97–103.
• Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31–46.
• Laviano, A., et al. (2020). Omega-3 fatty acids in cancer cachexia: Clinical evidence and future directions. Nutrients, 12(1), 236.
• Lalla, R.V., et al. (2014). MASCC/ISOO clinical practice guidelines for mucositis. Supportive Care in Cancer, 22(10), 2859–2868.
• Ligibel, J.A., et al. (2020). Obesity, metabolic health, and cancer. Cancer Epidemiology, Biomarkers & Prevention, 29(10), 1893–1908.
• Muscaritoli, M., et al. (2021). Cancer cachexia: Updated consensus on definition and diagnostic criteria. Clinical Nutrition, 40(6), 3541–3551.
• Redman, M.G., et al. (2021). The use of probiotics and prebiotics in cancer patients: A systematic review. Supportive Care in Cancer, 29(10), 5599–5610.
• Rock, C.L., et al. (2022). Nutrition and physical activity guidelines for cancer survivors. CA: A Cancer Journal for Clinicians, 72(3), 230–262.
• Zick, S.M., et al. (2009). Ginger for nausea and vomiting associated with chemotherapy: A randomized trial. Supportive Care in Cancer, 17(5), 563–572.
• Zhang, X., & Zhang, D. (2019). Nutrition and immune function in cancer patients. Current Opinion in Clinical Nutrition and Metabolic Care, 22(5), 401–407.

To learn more about Dr Ann-Mary Amber and her services, click here